Ron Bentsur - Sep 23, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Sep 23, 2022
Transactions value $
$11,775
Form type
4
Date filed
9/27/2022, 08:44 AM
Previous filing
Sep 6, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $7.93K +1K +0.03% $7.93 3.01M Sep 23, 2022 Direct F1
transaction NVCT Common Stock Purchase $3.85K +500 +0.02% $7.69 3.01M Sep 26, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.